查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1529646

切片检查引导系统市场规模、份额、趋势分析报告：按产品、应用、最终用途、地区和细分市场预测，2024-2030 年

Biopsy Guidance Systems Market Size, Share & Trends Analysis Report By Product (Stereotactic Guided Biopsy, Ultrasound Guided Biopsy, MRI Guided Biopsy), By Application, By End Use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格
简介目录

切片检查引导系统市场成长与趋势：

Grand View Research, Inc. 的最新报告显示，到 2030 年，全球切片检查引导系统市场规模预计将达到 15.8 亿美元。

预计2024年至2030年该市场将以6.1%的复合年增长率成长。癌症盛行率的增加、老年人口的增加、对非侵入性手术的需求增加、技术创新、政府措施的增加以及 COVID-19 的影响是市场的主要驱动因素。

切片检查是诊断癌症和其他慢性疾病的最重要的方法之一，通常用于诊断乳腺癌、脑癌、皮肤癌和前列腺癌。癌症盛行率的增加是市场成长的主要驱动力。例如，根据 Cancer.org 的数据，预计 2021 年美国将有约 190 万人新诊断出罹患癌症。由于切片检查引导系统是癌症早期诊断所需的关键要求之一，预计癌症病例数量的增加将在预测期内推动市场成长。

此外，市场也越来越偏好微创切片检查治疗。预计多种类型的技术和产品将在预测期内迅速扩展，例如机器人辅助切片检查引导系统、针活检枪和真空辅助核心切片检查系统。例如，2021 年 3 月，IZI Medical Products, LLC 推出了用于软组织切片检查的 Quick-Core 自动活检系统。这是一款轻型全自动切片检查设备，具有可靠性、品质和准确性。此外，人们对乳癌治疗和诊断的认识不断提高，预计将在预测期内进一步推动市场成长。

切片检查引导系统市场报告亮点

  • 立体定位切片检查占据市场主导地位，2023年占39.9%的份额。
  • 2023年，脑切片检查领域占据最大的市场收益占有率。脑部切片检查被认为是诊断无法手术切除的脑肿瘤最可靠的方法。
  • 康復中心细分市场在行业中占据主导地位，并在 2023 年占据最大的收益占有率。这可能是由于诊所越来越多地采用切片检查指导框架。
  • 北美切片检查引导系统市场在 2023 年以 45.4% 的收益占有率占据市场主导地位。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章切片检查引导系统市场变数、趋势、范围

  • 市场介绍/系统展望
  • 市场规模及成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 切片检查引导系统市场分析工具
    • 波特的分析
    • PESTEL分析

第四章切片检查引导系统市场：依产品估计和趋势分析

  • 细分仪表板
  • 切片检查引导系统市场：2023 年和 2030 年按产品分類的变异分析
  • 立体定位切片检查
  • 超音波引导切片检查
  • MRI导引切片检查

第五章切片检查引导系统市场：按应用估计和趋势分析

  • 细分仪表板
  • 切片检查引导系统市场：2023 年和 2030 年按应用分类的变化分析
  • 脑部切片检查
  • 乳房切片
  • 其他的

第六章切片检查引导系统市场：最终用途的估计和趋势分析

  • 细分仪表板
  • 切片检查引导系统市场：2023 年和 2030 年最终用途的变化分析
  • 医院
  • 专科诊所
  • 诊断中心
  • 研究/学术机构

第七章切片检查引导系统市场：区域估计和趋势分析

  • 2023 年和 2030 年切片检查引导系统市场占有率（按地区）
  • 北美洲
    • 2018-2030 年北美切片检查引导系统市场估计与预测
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 2018-2030年欧洲切片检查引导系统市场估计与预测
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 2018-2030 年亚太地区切片检查引导系统市场估计与预测
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 2018-2030 年拉丁美洲切片检查引导系统市场估计与预测
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 中东和非洲切片检查引导系统市场估计和预测，2018-2030 年
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 科威特

第八章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 企业热力图分析
  • 公司简介
    • Becton, Dickinson, and Company
    • Hologic, Inc.
    • Devicor Medical Products, Inc.
    • B. Braun Melsungen AG
    • ARGON MEDICAL
    • Boston Scientific Corporation
    • INRAD Inc.
    • Cook Medical
    • PLANMED OY
简介目录
Product Code: GVR-4-68039-395-9

Biopsy Guidance Systems Market Growth & Trends:

The global biopsy guidance systems market size is expected to reach USD 1.58 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to grow at a CAGR of 6.1% from 2024 to 2030. The increasing prevalence of cancer, rise in the geriatric population, growing demand for non-invasive procedures, technological innovations, a rising number of government initiatives, and impact of COVID-19 are the key driving factors for the market.

A biopsy is one of the most prominent procedures for diagnosing cancer amongst other chronic diseases, and it is commonly employed in the diagnosis of breast, brain, skin, and prostate cancer. The increasing prevalence of cancer is a major factor responsible for market growth. For instance, according to Cancer.org, in 2021, around 1.9 million new cancer cases are expected to be diagnosed in the US. Since the biopsy guidance system is one of the major requirements for the initial diagnosis of cancer, thus, rising number of cancer cases is anticipated to propel market growth over the forecast period

Furthermore, there is a rising preference for minimally invasive biopsy treatments in the market. During the forecast period, several types of technologies and products including robot-assisted biopsy guidance systems, needle-based biopsy guns, and vacuum-assisted core biopsy systems, are expected to expand rapidly. For instance, in March 2021, IZI Medical Products, LLC launched Quick-Core Auto Biopsy System for soft tissue biopsy. It is a lightweight, completely automatic biopsy device and provides reliability, quality, and accuracy. Additionally, rising awareness of breast cancer treatment and diagnosis will further boost market growth over the forecast period.

Biopsy Guidance Systems Market Report Highlights:

  • The stereotactic guided biopsy dominated the market and accounted for a share of 39.9% in 2023
  • The brain biopsy section accounted for the largest market revenue share in 2023. Brain biopsy is considered the most reliable method to diagnose brain tumors that cannot be surgically removed.
  • The healing centers segment dominated the industry and held the largest revenue share in 2023. It can be attributed to increased adoption of biopsy direction frameworks in clinics.
  • North America biopsy guidance system market dominated the market and accounted for revenue share of 45.4% in 2023.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Biopsy Guidance Systems Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Biopsy Guidance Systems Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Biopsy Guidance Systems Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Biopsy Guidance Systems Market: Product Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Stereotactic Guided Biopsy
    • 4.3.1. Stereotactic Guided Biopsy Guidance Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Ultrasound Guided Biopsy
    • 4.4.1. Ultrasound Guided Biopsy Guidance Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. MRI Guided Biopsy
    • 4.5.1. MRI Guided Biopsy Guidance Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Biopsy Guidance Systems Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Biopsy Guidance Systems Market: Application Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Brain Biopsy
    • 5.3.1. Brain Biopsy Guidance Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Breast Biopsy
    • 5.4.1. Breast Biopsy Guidance Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Others Biopsy Guidance Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Biopsy Guidance Systems Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Biopsy Guidance Systems Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
  • 6.3. Hospitals
    • 6.3.1. Biopsy Guidance Systems In Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Specialty Clinics
    • 6.4.1. Biopsy Guidance Systems In Specialty Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Diagnostic Centers
    • 6.5.1. Biopsy Guidance Systems In Diagnostic Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Research and Academic Institutes
    • 6.6.1. Biopsy Guidance Systems for Research and Academic Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Biopsy Guidance Systems Market: Regional Estimates & Trend Analysis

  • 7.1. Biopsy Guidance Systems Market Share, By Region, 2023 & 2030 (USD Billion)
  • 7.2. North America
    • 7.2.1. North America Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Canada Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1. Mexico Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. UK Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Germany Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. France Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Italy Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Spain Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Denmark Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Sweden Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Norway Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. China
      • 7.4.2.1. China Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Japan
      • 7.4.3.1. Japan Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. India Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. South Korea
      • 7.4.5.1. South Korea Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. Australia
      • 7.4.6.1. Australia Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Australia Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Argentina
      • 7.5.3.1. Brazil Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Middle East and Africa
    • 7.6.1. Middle East and Africa Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Saudi Arabia
      • 7.6.2.1. Saudi Arabia Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. UAE
      • 7.6.3.1. UAE Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. South Africa
      • 7.6.4.1. South Africa Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. South Africa Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Heat Map Analysis
  • 8.4. Company Profiles
    • 8.4.1. Becton, Dickinson, and Company
      • 8.4.1.1. Participant's Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Recent Developments/ Strategic Initiatives
    • 8.4.2. Hologic, Inc.
      • 8.4.2.1. Participant's Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Recent Developments/ Strategic Initiatives
    • 8.4.3. Devicor Medical Products, Inc.
      • 8.4.3.1. Participant's Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Recent Developments/ Strategic Initiatives
    • 8.4.4. B. Braun Melsungen AG
      • 8.4.4.1. Participant's Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Recent Developments/ Strategic Initiatives
    • 8.4.5. ARGON MEDICAL
      • 8.4.5.1. Participant's Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Recent Developments/ Strategic Initiatives
    • 8.4.6. Boston Scientific Corporation
      • 8.4.6.1. Participant's Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Recent Developments/ Strategic Initiatives
    • 8.4.7. INRAD Inc.
      • 8.4.7.1. Participant's Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Recent Developments/ Strategic Initiatives
    • 8.4.8. Cook Medical
      • 8.4.8.1. Participant's Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Recent Developments/ Strategic Initiatives
    • 8.4.9. PLANMED OY
      • 8.4.9.1. Participant's Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Recent Developments/ Strategic Initiatives